U.S. RESEARCH ROUNDUP-Magellan Midstream Partners LP, Onsemi, Viking Therapeutics

Calliditas Therapeutics AB

17/05/2023 07:47

May 17 (Reuters) - Wall Street securities analysts revised their ratings and price
targets on several U.S.-listed companies, including Magellan Midstream Partners LP, Onsemi and
Viking Therapeutics, on Wednesday. 

    HIGHLIGHTS
                 * Magellan Midstream Partners LP  MMP.N : RBC cuts to sector perform from outperform 
 
                 * Onsemi  ON.O : Piper Sandler raises target price to $100 from $85 
 
                 * Viking Therapeutics Inc  VKTX.O : Oppenheimer raises target price to $40 from $35 
 
    
Following is a summary of research actions on U.S. companies reported by Reuters on Wednesday.
Stock entries are in alphabetical order.     

                 * Agios Pharmaceuticals Inc  AGIO.O : JP Morgan raises target price to $33 from $32 
 
                 * Antero Resources Corp  AR.N : Scotiabank cuts target price to $27 from $31 
 
                 * Apollo Commercial Real Estate Finance Inc  ARI.N : Credit Suisse cuts PT to $11 from $12 
 
                 * Ares Commercial Real Estate Corp  ACRE.N : Credit Suisse cuts target to $11 from $13 
 
                 * Blackstone Mortgage Trust Inc  BXMT.N : Credit Suisse cuts target price to $21 from $26 
 
                 * BP  BP.N : Jefferies cuts target price to $39.30 from $40.10 
 
                 * Calliditas Therapeutics AB  CALT.O : Jefferies raises target price to $54 from $53 
 
                 * Chesapeake Energy Corp  CHK.O : Scotiabank cuts target price to $95 from $100 
 
                 * CNX Resources Corp  CNX.N : Scotiabank cuts target price to $18 from $21 
 
                 * Coherus Biosciences Inc  CHRS.O : TD Cowen cuts target price to $15 from $30 
 
                 * Doximity Inc  DOCS.N : Canaccord Genuity cuts target price to $40 from $41 
 
                 * Doximity Inc  DOCS.N : Evercore ISI cuts target price to $32 from $33 
 
                 * EQT Corp  EQT.N : Scotiabank cuts target price to $49 from $52 
 
                 * Ginkgo Bioworks Holdings Inc  DNA.N : BTIG cuts target price to $2.50 from $3 
 
                 * Granite Point Mortgage Trust Inc  GPMT.N : Credit Suisse cuts target price to $7 from $9 
 
                 * Home Depot Inc  HD.N : Piper Sandler cuts target price to $276 from $300 
 
                 * Home Depot Inc  HD.N : Telsey Advisory Group cuts target price to $315 from $340 
 
                 * Ideaya Biosciences Inc  IDYA.O : JP Morgan cuts target price to $28 from $30 
 
                 * Lucid Diagnostics Inc  LUCD.O : Needham raises target price to $2.8 from $2.6 
 
                 * Lument Finance Trust Inc  LFT.N : Raymond James cuts target price to $2.5 from $2.75 
 
                 * Magellan Midstream Partners LP  MMP.N : RBC cuts to sector perform from outperform 
 
                 * Magellan Midstream Partners LP  MMP.N : RBC raises target price to $66 from $59 
 
                 * National Fuel Gas Co  NFG.N : Scotiabank cuts target price to $73 from $77 
 
                 * Newell Brands Inc  NWL.O : Jefferies cuts target price to $18 from $19 
 
                 * Newell Brands Inc  NWL.O : Raymond James cuts target price to $15 from $17 
 
                 * ONEOK Inc  OKE.N : RBC cuts target price to $66 from $75 
 
                 * Onsemi  ON.O : Jefferies raises target price to $99 from $93 
 
                 * Onsemi  ON.O : Piper Sandler raises target price to $100 from $85 
 
                 * Oramed Pharmaceuticals Inc  ORMP.O : Canaccord Genuity cuts target price to $2 from $3 
 
                 * P10 Inc  PX.N : JP Morgan cuts target price to $14.5 from $15 
 
                 * P10 Inc  PX.N : Stephens cuts target price to $14 from $15 
 
                 * Phenomex Inc  CELL.O : Berenberg cuts target price to $9 from $10 
 
                 * Presidio Property Trust Inc  SQFT.O : Colliers Securities cuts target to $1 from $1.1 
 
                 * Rapt Therapeutics Inc  RAPT.O : JP Morgan cuts target price to $39 from $42 
 
                 * RPM International Inc  RPM.N : RBC cuts target price to $84 from $90 
 
                 * Starwood Property Trust Inc  STWD.N : Credit Suisse cuts target price to $19 from $22 
 
                 * Stratasys Ltd  SSYS.O : Needham raises target price to $19 from $15 
 
                 * Vera Therapeutics Inc  VERA.O : JP Morgan raises target price to $23 from $22 
 
                 * Viking Therapeutics Inc  VKTX.O : Oppenheimer raises target price to $40 from $35 
 
                 * Viking Therapeutics Inc  VKTX.O : SVB Securities raises target price to $28 from $23 
 
 
 (Compiled by Bengaluru Newsroom)
 ((Diaries@thomsonreuters.com))